Articles by : Tom Mirga, Editor at Large

Health centers leaders are applauding the Biden administration’s decision yesterday to push back, from today until March 22, the effective date of the Trump administration’s controversial final rule to require health centers to provide insulin and injectable epinephrine to low-income

Alex Azar, at 8:45 a.m. Eastern yesterday in one of his last acts as U.S. Health and Human Services (HHS) secretary, appointed the six voting and two ex-officio non-voting members of the 340B program’s new administrative dispute resolution (ADR) board.

U.S. Public Health Service (PHS) Rear Adm. Krista Pedley, who has led the federal 340B drug pricing program for more than a decade, has been promoted within the U.S. Health Resources and Services Administration (HRSA) in conjunction with a major

President Biden has accepted the resignation of U.S. Health Resources and Services Administration (HRSA) Administrator Tom Engels, whom former President Trump appointed to the post in November 2019. Diana Espinosa, a career civil servant who has served as HRSA’s deputy

Community health center leaders are concerned that the Biden administration yesterday asked, but did not order, the U.S. Health and Human Services Department (HHS) to postpone tomorrow’s scheduled implementation of a controversial Trump administration final rule that will require health

Outgoing U.S. Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma both referred to 340B—obliquely in Azar’s case, directly in Verma’s—in recent farewell remarks.

In an interview with Modern Healthcare